Eusol Biotech Co.,Ltd. (6652.TWO)
TWD 6.05
(-22.34%)
TWD 6.05
(-22.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -44.95 Million TWD | -504.2% |
| 2022 | 11.12 Million TWD | 111.69% |
| 2021 | -95.15 Million TWD | -13.34% |
| 2020 | -83.95 Million TWD | 6.66% |
| 2019 | -89.93 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -9757.50 TWD | 4.29% |
| 2024 Q2 | -9757.50 TWD | -6.16% |
| 2023 Q4 | -10.19 Thousand TWD | 0.0% |
| 2023 Q3 | -10.19 Thousand TWD | -4.73% |
| 2023 FY | - TWD | -504.2% |
| 2023 Q2 | -9734.50 TWD | 0.0% |
| 2023 Q1 | -9734.50 TWD | 12.53% |
| 2022 Q3 | -11.12 Thousand TWD | 0.0% |
| 2022 FY | - TWD | 111.69% |
| 2022 Q4 | -11.12 Thousand TWD | 0.0% |
| 2021 FY | - TWD | -13.34% |
| 2020 FY | - TWD | 6.66% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 2.796% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 111.42% |
| Level Biotechnology Inc. | 98.7 Million TWD | 145.541% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -0.474% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 37.668% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -78.144% |
| GlycoNex Incorporation | -126.82 Million TWD | 64.557% |
| VBI | -6.97 Million TWD | -544.736% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 68.718% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 306.103% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -153.588% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 56.617% |
| Visgeneer Inc. | 973 Thousand TWD | 4719.836% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 86.759% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 104.8% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 145.024% |
| Neith Corporation | -33.61 Million TWD | -33.743% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 95.465% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -2487.853% |
| Enimmune corporation | -228.96 Million TWD | 80.368% |
| TaiRx, Inc. | -208.64 Million TWD | 78.456% |
| CHO Pharma, Inc. | -277.73 Million TWD | 83.815% |
| EirGenix Inc. | -664.4 Million TWD | 93.234% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 160.824% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 165.012% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 95.804% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 60.258% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 229.029% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 27.895% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -70.916% |
| RBC Bioscience Corporation | 36.54 Million TWD | 222.995% |
| BiOptic Inc. | 65.03 Million TWD | 169.115% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 93.413% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -36.19% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 18.144% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 110.368% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 43.862% |
| NaviFUS Corp. | -55.79 Million TWD | 19.435% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -170.822% |
| Sinew Pharma Inc. | -163.63 Million TWD | 72.529% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 26.909% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 123.363% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 80.17% |
| AP Biosciences Inc | -325.51 Million TWD | 86.191% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 95.697% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -25.4% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 254.312% |
| Intech Biopharm Corporation | -219.58 Million TWD | 79.529% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 93.333% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 72.055% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 106.857% |
| TCI GENE Inc. | 25.98 Million TWD | 273.015% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 59.371% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 84.16% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 69.205% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 424.556% |
| PharmaEngine, Inc. | 347.3 Million TWD | 112.943% |
| Savior Lifetec Corporation | 219.6 Million TWD | 120.469% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 126.099% |
| OBI Pharma, Inc. | -855.08 Million TWD | 94.743% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 51.437% |
| Acepodia, Inc. | -764.51 Million TWD | 94.12% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 90.23% |